Dentsply Sirona Inc. (XRAY)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY
NEW YORK, NY / ACCESSWIRE / November 6, 2024 / Pomerantz LLP is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against DENTSPLY SIRONA Inc. (XRAY) and Encourages Investors to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / November 6, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against DENTSPLY SIRONA Inc. (XRAY) And Encourages Investors to Reach Out
NEW YORK CITY, NY / ACCESSWIRE / November 5, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
Should You Buy, Sell or Hold DENTSPLY SIRONA Before Q3 Earnings?
XRAY's third-quarter results are likely to reflect growth in the Wellspect Healthcare business and Orthodontic segment amid foreign exchange headwinds.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against DENTSPLY SIRONA Inc. (XRAY) And Encourages Stockholders to Reach Out
NEW YORK CITY, NY / ACCESSWIRE / November 4, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
Bronstein, Gewirtz & Grossman, LLC Is Investigating DENTSPLY SIRONA Inc. (XRAY) And Encourages Stockholders to Connect
NEW YORK CITY, NY / ACCESSWIRE / November 3, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / Pomerantz LLP is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
DENTSPLY SIRONA Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / November 1, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against DENTSPLY SIRONA Inc. (XRAY) and Encourages Stockholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / October 31, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
Dentsply Sirona Shares Fall After Suspension of Byte Aligner Products
XRAY suspends Byte Aligner sales, citing regulatory review with the FDA, shifting resources to bolster other business areas amid compliance efforts.
Dentsply Sirona voluntarily suspends sales of its teeth aligners
Dentsply Sirona said on Thursday it was voluntarily suspending sales and marketing of its Byte teeth aligners and Impression Kits as it conducts a review of certain regulatory requirements related to these products.
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
XRAY continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.
